Gastroduodenal intussusception secondary to gastrointestinal stromal tumour is a very rare cause for intestinal obstruction. The diagnosis of this condition can be challenging, as symptoms are often non-specific and intermittent. This article reports a case where the diagnosis was made preoperatively with abdominal imaging and was treated by a combination of endoscopic reduction and laparoscopic resection.
INVESTIGATIONS
The only abnormal finding on haematological investigations was a mildly elevated urea level, which was consistent with her dehydrated state secondary to vomiting. She underwent a contrast-enhanced abdominal CT scan and this demonstrated a dilated stomach with intussusception of the distal stomach extending as far as the second part of the duodenum. The intussusception lead point appeared to be a polypoid gastric mass.
DIFFERENTIAL DIAGNOSIS
Distal gastric tumour, foreign body, tumour of the duodenum, ectopic pancreatic tumours and head of the pancreas tumours.
TREATMENT
Intraoperative gastroscopy revealed a distended stomach with a polypoid mass intussuscepted into the first part of the duodenum. Endoscopic reduction was carried out and the polyp appeared to originate from the distal body and antrum of the stomach.Laparoscopy did not reveal any evidence of metastases and laparoscopic exvagination of the gastric mass was per-formed via anterior gastrotomy. A laparoscopic linear stapler (Endo GIA Ultra Universal Stapler; Covidien Surgical, Mansfield, MA, USA) was used to take a wedge resection of the stomach encompassing the lesion. Several applications of the stapler were required to complete the resection. The mass was placed in the endoscopic retrieval bag and removed through the umbilical port. Air insufflation of the stomach was carried out with a gastroscope and the no evi-dence of air leakage was seen under direct laparoscopic visu-alisation. The patient was returned to the postanaesthetic care unit and the specimen was sent for histopathological analysis.
OUTCOME AND FOLLOW-UP
Postoperatively the patient was allowed clear fluids the fol-lowing morning and was started on a soft diet on day 3. She was discharged home on postoperative day 4. On follow-up, she developed a minor superficial wound infec-tion at the umbilical port wound. This was treated with oral antibiotics and it resolved quickly with an otherwise uneventful recovery.
The surgical specimen was 45×33×34mm in size. Histopathological analysis of the polypoid mass showed an admixture of spindle and epithelioid cells and areas of myxoid change with the presence of vacuolated cells. Immunohistochemistry with c-kit antibody confirmed the diagnosis of gastrointestinal stromal tumour.
DISCUSSION
Gastroduodenal intussusception is a rare cause of intes-tinal obstruction. When it occurs, the most common aeti-ologies are intussusception of the gastric remnant through a gasrtojejunal anastomosis or of gastric polyp throughthe pylorus into the duodenum. 3 It presents with a variety of symptoms that can be acute, intermittent or chronic. An epigastric mass may be palpated on physical examination. The widespread availability of abdominal imaging has made preoperative diagnosis of gastroduode-nal intussusception far more common. 4 5 CT is especially useful and can provide excellent anatomic detail of the intussusception morphology.
Gastroduodenal intussusception secondary to gastro-intestinal stomaltumours (GIST) appears to be a very rare cause for intestinal obstruction. It is caused by pro-lapse of the tumour and subsequent invagination of a portion of full thickness gastric wall into the duodenum.
GISTs are mesenchymal neoplasms and are thought to develop from the interstitial cells of Cajal. These tumours have been reported ranging in size from smaller than 1 cm to as large as 40 cm in diameter. The annual incidence and prevalence of GIST has been reported to be 14.5 per million population and 129 per million population, respectively. 6 They can occur at any point of the GI tract but occur most commonly in the stomach (47-60% of cases). Most (50-80%) GISTs arise because of a mutation in a gene called c-kit. The c-kit proto-oncogene encodes KIT, which is a transmembrane tyrosine kinase receptor. All GIST tumours should be considered to have malignant potential and no GIST tumour can be correctly classified as 'benign'. Predictors of behaviour include size, mitotic rate, location, complete surgical resection and tumour rupture. Tumours<2 cm in size with a mitotic rate of <5/50 high-power field have been shown to have lower risk of recurrence.
Surgery offers the only treatment option that can definitively cure the disease and the standard initial treat-ment for non-metastatic disease is en-bloc resection. Lymphadenectomy not usually indicated. Five-year sur-vival rates are between 48% and 65% after complete resec-tion. GISTs are notoriously resistant to chemotherapeutic agents. The only effective, specific, non-surgical therapy for GISTs is imatinib (Gleevec; Novartis, East Hanover, NJ, USA). This is a selective tyrosine kinase inhibitor with action against mutant c-kit as it occurs in associ-ation with GISTs.
Imatinib has a 40-70% response rate in metastatic or inoperable cases. The 2-year survival of patients withadvanced disease has risen to 75-80% following treatment with imatinib. 7 8 It is considered a significant break-through in antineoplastic drug therapy because it is tar-geted against a specific molecular derangement.
Learning Points
▸ Gastrointestinal intussusception due to gastrointestinal stromal tumour is an exceedingly rare cause for intestinal obstruction.
▸ Preoperative diagnosis can be challenging as symptoms are often vague, intermittent and long standing.
▸ CT is very useful in the diagnosis and in demonstrating the morphology of the intussusception.
▸ A combination of endoscopic reduction and laparoscopic resection is a safe approach to treatment.
